UCB S.A. (ADR)
General ticker "UCBJY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $40.9B (TTM average)
UCB S.A. (ADR) follows the US Stock Market performance with the rate: 54.3%.
Estimated limits based on current volatility of 1.1%: low 140.23$, high 143.48$
Factors to consider:
- Company pays dividends (annually): last record date 2025-04-28, amount 0.79$ (Y0.56%)
Short-term UCBJY quotes
Long-term UCBJY plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €5,517.00MM | €5,252.00MM | €6,152.00MM |
| Operating Expenses | €4,932.00MM | €4,648.00MM | €4,828.00MM |
| Operating Income | €585.00MM | €604.00MM | €1,324.00MM |
| Non-Operating Income | €-74.00MM | €-163.00MM | €-161.00MM |
| Interest Expense | €71.00MM | €144.00MM | €171.99MM |
| R&D Expense | €1,670.00MM | €1,630.00MM | €1,781.00MM |
| Income(Loss) | €511.00MM | €441.00MM | €1,163.00MM |
| Taxes | €91.00MM | €98.00MM | €98.00MM |
| Profit(Loss)* | €418.00MM | €343.00MM | €1,065.00MM |
| Stockholders Equity | €9,064.00MM | €8,975.00MM | €10,029.00MM |
| Inventory | €907.00MM | €1,031.00MM | €1,309.00MM |
| Assets | €15,868.00MM | €15,539.00MM | €17,347.00MM |
| Operating Cash Flow | €1,119.00MM | €761.00MM | €1,242.00MM |
| Capital expenditure | €371.00MM | €316.00MM | €322.00MM |
| Investing Cash Flow | €-1,580.00MM | €-440.00MM | €282.00MM |
| Financing Cash Flow | €70.00MM | €-308.00MM | €-818.00MM |
| Earnings Per Share** | €1.10 | €0.88 | €2.80 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.